By Zachary Zagger ( February 6, 2015, 3:59 PM EST) -- A proxy battle is breaking out between the board of DuPont Co. and activist investor Nelson Peltz's hedge fund Trian Fund Management LP, one of the chemical conglomerate's largest shareholders, with $1.9 billion of its shares, after the company rejected three of Trian's board nominees, including Peltz, claiming that the activist refused to negotiate....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.